EUVIMEDEUVIMED entdecken
Crossref

Phenotyping of Pulmonary Arterial Hypertension Associated With Congenital Heart Disease Using Latent Class Analysis

Qimou Li, Qingyun Yu, Gangcheng Zhang, Hongyan Tian, Zaixin Yu, Caojin Zhang, Yucheng Chen, Yuhao Liu, Weifeng Wu, Xianyang Zhu, Xiulong Zhu, Zhenwen Yang und 5 weitere

CHEST · 2026-06

DOI: 10.1016/j.chest.2026.06.019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CHEST, 2026-06. Verfasst von Qimou Li und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Vascular Disease, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking …. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD) is characterized by substantial prognostic and therapeutic heterogeneity. Conventional clinical and anatomical-pathophysiological classifications fail to fully capture these intricacies. Unsupervised clustering approaches such as latent class analysis (LCA) have been used to address this limitation. RESEARCH QUESTION: Can LCA-derived phenogroups refine risk stratification and predict PAH-targeted treatment responses in adult patients with PAH-CHD? STUDY DESIGN AND METHODS: Adult patients with PAH-CHD (N = 889) from a multicenter prospective registry were stratified into post- and pre-tricuspid shunt subsets. LCA was performed in each subset using 28 candidate clinical, laboratory, and hemodynamic variables. Ten-year survival and the effect of PAH-targeted therapy across phenogroups were evaluated. RESULTS: LCA identified 4 phenogroups in each subset with distinct phenotyping patterns. In post-tricuspid shunts, Group 1 ("adaptation with open shunt") exhibited preserved right ventricular function and the best survival despite high afterload. Group 3 ("maladaptation and failure") and Group 4 ("closed shunt and failure") faced 2- to 3-fold higher mortality than Group 1. Notably, Group 2 ("hyperkinetic state") uniquely benefited from combination therapy (Pinteraction = .026). In pre-tricuspid shunts, Group 1 ("high shunt and mild resistance") and Group 3 ("younger female and low inflammation") exhibited preserved survival despite varying afterloads. However, Group 2 ("older male and comorbidities") had significantly higher mortality and an attenuated treatment response (Pinteraction = .037) despite sharing mild hemodynamics with Group 1. Group 4 ("high resistance and failure") faced severe hypoxemia and the worst prognosis. INTERPRETATION: LCA was shown to successfully stratify patients with PAH-CHD into distinct phenogroups with varied clinical profiles, survival, and treatment responses. This data-driven phenotyping system provides a novel approach for risk stratification and may guide personalized clinical decision-making. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov; No.: NCT01417338; URL: www. CLINICALTRIALS: gov.

Schlagwörter

Stichwörter der Autor:innen

congenital heart diseasemachine learningprognosispulmonary arterial hypertensiontreatment

Autor:innen und Institutionen

  • Department of Pulmonary Vascular Disease, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, State Key Laboratory of Cardiovascular Disease,…
  • Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
  • Division of Pulmonary Vascular Disease, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • Department of Peripheral Vascular Diseases, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Department of Cardiology, Xiangya Hospital, Central South University, Changsha, China.
  • Department of Cardiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.

Förderung

  • Ministry of Science and Technology of the People's Republic of China

Zitieren

APA

Li, Q., Yu, Q., Zhang, G., Tian, H., Yu, Z., Zhang, C., Chen, Y., Liu, Y., Wu, W., Zhu, X., Zhu, X., Yang, Z., Xiong, C., Han, H., Wu, Y., Gu, Q., & He, J. (2026). Phenotyping of Pulmonary Arterial Hypertension Associated With Congenital Heart Disease Using Latent Class Analysis. CHEST. https://doi.org/10.1016/j.chest.2026.06.019

Vancouver

Li Q, Yu Q, Zhang G, Tian H, Yu Z, Zhang C, et al. Phenotyping of Pulmonary Arterial Hypertension Associated With Congenital Heart Disease Using Latent Class Analysis. CHEST. 2026. doi:10.1016/j.chest.2026.06.019

BibTeX
@article{Li2026,
  author = {Li, Qimou and Yu, Qingyun and Zhang, Gangcheng and Tian, Hongyan and Yu, Zaixin and Zhang, Caojin and Chen, Yucheng and Liu, Yuhao and Wu, Weifeng and Zhu, Xianyang and Zhu, Xiulong and Yang, Zhenwen and Xiong, Changming and Han, Huijun and Wu, Yanqing and Gu, Qing and He, Jianguo},
  title = {Phenotyping of Pulmonary Arterial Hypertension Associated With Congenital Heart Disease Using Latent Class Analysis},
  journal = {CHEST},
  year = {2026},
  doi = {10.1016/j.chest.2026.06.019}
}
Kostenlos starten →